The genetic polymorphism of drug transporters: functional analysis approaches.
about
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionConsiderations for extrapolating in vivo bioequivalence data across species and routes.Pharmacogenomics in Japan.Characteristics of successful recruitment in prospective pediatric pharmacogenetic studiesPharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failurePharmacogenetics and anesthesiologists.Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System.Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations.Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.Hepatocyte nuclear factor-4{alpha} regulates the human organic anion transporter 1 gene in the kidney.Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease.Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity.Role of ABC transporters in cancer chemotherapy.Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics.Rapid and cost-effective SNP detection method: application of SmartAmp2 to pharmacogenomics research.ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients.ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.Rapid genotyping of the OATP1B1 polymorphisms A388G and T521C with real-time PCR FRET assays.Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study
P2860
Q24273350-37F7DE0A-F9B2-4C8A-AD9B-39D00F667F88Q34194145-011B0ABC-4DA1-43EA-92F4-60C17AF65304Q35821207-BF4042AC-2B20-4848-9A12-659D7025BFF9Q35871392-CEF1AC85-20B1-40E8-A1DF-A39F5EE9838DQ35871996-5473BEFB-23FF-4829-B479-988DBD3E7DF6Q36317007-CB9B7878-35BD-4B8F-A495-C9C2D5179290Q36544966-C5E54777-9163-4468-A8D5-6F5E07C5E21DQ36745692-E81287B8-5398-45BB-A09D-3E0C183CB2B0Q37627874-424BED77-AF39-4D0F-9A1C-3855ECD67767Q38183877-26D8EDFB-FC08-4C27-B0FE-F3EDFEBF643DQ38303968-C7ECC64A-985E-4E11-860B-C82ED7C02431Q38734885-5ACF3880-7DBF-40D7-8A26-DE1EA6BE46F5Q39892581-7B75428A-AE17-4D25-9755-713049376812Q42637698-7F156A93-454D-4F14-B88B-ED71D1277C4AQ44347749-DF04C91A-9166-4FD3-9BEA-00631C6FCE9BQ44703823-AD2CBD41-ABD4-4E78-A985-A4B0CE2397D4Q48404747-E208124A-B7E9-4103-A592-BDE27F9487ABQ48510594-BF2FDD86-CC89-4FFB-8602-091CBD23D71AQ54654987-EB0D55A9-D7C0-476B-9026-06551767CADBQ57550187-91B1276A-CB2E-40F4-A2CE-37D7382A3A51
P2860
The genetic polymorphism of drug transporters: functional analysis approaches.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The genetic polymorphism of drug transporters: functional analysis approaches.
@ast
The genetic polymorphism of drug transporters: functional analysis approaches.
@en
type
label
The genetic polymorphism of drug transporters: functional analysis approaches.
@ast
The genetic polymorphism of drug transporters: functional analysis approaches.
@en
prefLabel
The genetic polymorphism of drug transporters: functional analysis approaches.
@ast
The genetic polymorphism of drug transporters: functional analysis approaches.
@en
P2093
P1433
P1476
The genetic polymorphism of drug transporters: functional analysis approaches
@en
P2093
Akira Tsuji
Hitoshi Endou
Kenichi Inui
Morimasa Wada
Toshihisa Ishikawa
Yasuhiro Sumino
Yoshimichi Sai
P356
10.1517/PHGS.5.1.67.25683
P577
2004-01-01T00:00:00Z